- Citations, last 5 years
- 512
- Works, last 5 years
- 55
- h-index
- 26
- Scientists listed
- 8
- Grants since 2016
- 17
Grants received
2023–2026 · research · R44
Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity
Anthony Schmitt · Arima Genomics (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Scalable single-cell workflow for multiomic analyses of chromatin interactions, accessibility, gene expression and cell surface proteins to unravel mechanisms of cellular diversity
Anthony Schmitt · Arima Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A low-input compatible, end-to-end kitted HiChIP workflow for concurrent analyses of transcriptional protein binding and chromatin interactions toward a mechanistic understanding of gene regulation
Anthony Schmitt · Arima Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A low-input compatible, end-to-end kitted HiChIP workflow for concurrent analyses of transcriptional protein binding and chromatin interactions toward a mechanistic understanding of gene regulation
Anthony Schmitt · Arima Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A scalable kit-based assay for multi-omic analyses of transcriptional protein binding and chromatin interactions from ultra-low input frozen and FFPE samples at single-cell resolution
Anthony Schmitt · Arima Genomics (United States) · funded by National Institutes of Health
2021–2023 · research · R44
A scalable kit-based assay for multi-omic analyses of transcriptional protein binding and chromatin interactions from ultra-low input frozen and FFPE samples at single-cell resolution
Anthony Schmitt · Arima Genomics (United States) · funded by National Institutes of Health
2020–2025 · research · R44
Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2020–2022 · research · R44
Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2020–2025 · research · R44
Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing for a wide range of applications
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2017–2019 · research · R44
Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing for a wide range of applications
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2016–2017 · research · R43
Maximal resolution and full-length phasing for next-generation MHC-typing
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2016–2017 · research · R43
Maximal resolution and full-length phasing for next-generation MHC-typing
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2016–2017 · research · R43
Non-invasive determination of complete fetal genomes from cfDNA using HaploSeq
Siddarth Selvaraj · Arima Genomics (United States) · funded by National Institutes of Health
2015–2020 · research · R44
Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information
Jesse R Dixon · Arima Genomics (United States) · funded by National Institutes of Health
2015–2020 · research · R44
Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information
Jesse R Dixon · Arima Genomics (United States) · funded by National Institutes of Health